S&P 500   3,324.99 (+0.56%)
DOW   27,122.56 (+1.10%)
QQQ   270.76 (+0.14%)
AAPL   438.08 (-0.13%)
MSFT   212.87 (-0.20%)
FB   250.57 (+0.30%)
GOOGL   1,485.00 (+0.79%)
AMZN   3,192.08 (+1.70%)
NVDA   452.33 (+0.72%)
CGC   19.17 (-0.78%)
BABA   263.22 (+0.39%)
TSLA   1,480.49 (-0.44%)
MU   50.99 (-0.60%)
GE   6.16 (+0.33%)
AMD   85.56 (+0.61%)
T   29.81 (-0.67%)
F   6.99 (+1.90%)
ACB   10.64 (-0.84%)
GILD   69.25 (-2.30%)
NFLX   505.29 (-0.85%)
DIS   129.25 (+10.20%)
BAC   25.46 (+1.80%)
BA   173.65 (+5.20%)
S&P 500   3,324.99 (+0.56%)
DOW   27,122.56 (+1.10%)
QQQ   270.76 (+0.14%)
AAPL   438.08 (-0.13%)
MSFT   212.87 (-0.20%)
FB   250.57 (+0.30%)
GOOGL   1,485.00 (+0.79%)
AMZN   3,192.08 (+1.70%)
NVDA   452.33 (+0.72%)
CGC   19.17 (-0.78%)
BABA   263.22 (+0.39%)
TSLA   1,480.49 (-0.44%)
MU   50.99 (-0.60%)
GE   6.16 (+0.33%)
AMD   85.56 (+0.61%)
T   29.81 (-0.67%)
F   6.99 (+1.90%)
ACB   10.64 (-0.84%)
GILD   69.25 (-2.30%)
NFLX   505.29 (-0.85%)
DIS   129.25 (+10.20%)
BAC   25.46 (+1.80%)
BA   173.65 (+5.20%)
S&P 500   3,324.99 (+0.56%)
DOW   27,122.56 (+1.10%)
QQQ   270.76 (+0.14%)
AAPL   438.08 (-0.13%)
MSFT   212.87 (-0.20%)
FB   250.57 (+0.30%)
GOOGL   1,485.00 (+0.79%)
AMZN   3,192.08 (+1.70%)
NVDA   452.33 (+0.72%)
CGC   19.17 (-0.78%)
BABA   263.22 (+0.39%)
TSLA   1,480.49 (-0.44%)
MU   50.99 (-0.60%)
GE   6.16 (+0.33%)
AMD   85.56 (+0.61%)
T   29.81 (-0.67%)
F   6.99 (+1.90%)
ACB   10.64 (-0.84%)
GILD   69.25 (-2.30%)
NFLX   505.29 (-0.85%)
DIS   129.25 (+10.20%)
BAC   25.46 (+1.80%)
BA   173.65 (+5.20%)
S&P 500   3,324.99 (+0.56%)
DOW   27,122.56 (+1.10%)
QQQ   270.76 (+0.14%)
AAPL   438.08 (-0.13%)
MSFT   212.87 (-0.20%)
FB   250.57 (+0.30%)
GOOGL   1,485.00 (+0.79%)
AMZN   3,192.08 (+1.70%)
NVDA   452.33 (+0.72%)
CGC   19.17 (-0.78%)
BABA   263.22 (+0.39%)
TSLA   1,480.49 (-0.44%)
MU   50.99 (-0.60%)
GE   6.16 (+0.33%)
AMD   85.56 (+0.61%)
T   29.81 (-0.67%)
F   6.99 (+1.90%)
ACB   10.64 (-0.84%)
GILD   69.25 (-2.30%)
NFLX   505.29 (-0.85%)
DIS   129.25 (+10.20%)
BAC   25.46 (+1.80%)
BA   173.65 (+5.20%)
Log in

NASDAQ:HEBTHebron Technology Stock Price, Forecast & News

$18.40
+0.40 (+2.22 %)
(As of 08/5/2020 12:22 PM ET)
Add
Compare
Today's Range
$18.15
Now: $18.40
$18.81
50-Day Range
$13.97
MA: $15.74
$17.53
52-Week Range
$1.89
Now: $18.40
$23.99
Volume1,598 shs
Average Volume48,584 shs
Market Capitalization$299.37 million
P/E RatioN/A
Dividend YieldN/A
Beta1.55
Hebron Technology Co., Ltd., through its subsidiaries, engages in the research, development, manufacture, and installation of valves, pipe fittings, and other products primarily for use in pharmaceutical engineering sector in the People's Republic of China. The company offers diaphragm valves, angle seat valves, sanitary centrifugal and liquid-ring pumps, clean-in-place return pumps, sanitary ball valves, and sanitary pipe fittings. It also provides pipeline design, installation, construction, ongoing maintenance, and after-sales services. The company offers its fluid equipment and installation services for use in the pharmaceutical, biological, food and beverage, and other clean industries. Hebron Technology Co., Ltd. was founded in 2005 and is headquartered in Wenzhou, the People's Republic of China.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.3Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.46 out of 5 stars


Industry, Sector and Symbol

Industry Miscellaneous fabricated metal products
Sub-IndustryN/A
Current SymbolNASDAQ:HEBT
CUSIPN/A
CIKN/A
Phone86-577-8689-5678

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$21.10 million
Cash Flow$0.26 per share
Book Value$3.32 per share

Profitability

Miscellaneous

Employees89
Market Cap$299.37 million
Next Earnings DateN/A
OptionableNot Optionable
$18.40
+0.40 (+2.22 %)
(As of 08/5/2020 12:22 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive HEBT News and Ratings via Email

Sign-up to receive the latest news and ratings for HEBT and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Hebron Technology (NASDAQ:HEBT) Frequently Asked Questions

How has Hebron Technology's stock been impacted by COVID-19 (Coronavirus)?

Hebron Technology's stock was trading at $6.68 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, HEBT shares have increased by 175.4% and is now trading at $18.40.
View which stocks have been most impacted by Coronavirus
.

Has Hebron Technology been receiving favorable news coverage?

Press coverage about HEBT stock has trended somewhat negative recently, according to InfoTrie. The research firm scores the sentiment of news coverage by analyzing more than six thousand blog and news sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Hebron Technology earned a news impact score of -1.0 on InfoTrie's scale. They also gave headlines about the industrial products company a news buzz of 5.0 out of 10, meaning that recent news coverage is somewhat likely to have an impact on the company's share price in the next several days.
View the latest news about Hebron Technology
.

Are investors shorting Hebron Technology?

Hebron Technology saw a increase in short interest during the month of June. As of June 30th, there was short interest totaling 809,200 shares, an increase of 28.7% from the June 15th total of 628,600 shares. Based on an average daily volume of 109,200 shares, the days-to-cover ratio is currently 7.4 days. Approximately 9.6% of the company's shares are short sold.
View Hebron Technology's Current Options Chain
.

Who are some of Hebron Technology's key competitors?

What other stocks do shareholders of Hebron Technology own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Hebron Technology investors own include Allena Pharmaceuticals (ALNA), Matinas BioPharma (MTNB), AbbVie (ABBV), Axsome Therapeutics (AXSM), British American Tobacco (BTI), Energy Transfer LP Unit (ET), Gilead Sciences (GILD), Huntington Bancshares (HBAN), Invesco (IVZ) and KeyCorp (KEY).

Who are Hebron Technology's key executives?

Hebron Technology's management team includes the following people:
  • Mr. Anyuan Sun, CEO & Chairman of Board (Age 42)
  • Mr. Xiaoliang Xue, Chief Technical Officer (Age 34)
  • Ms. Jun Zheng, Chief HR Officer (Age 40)
  • Mr. Xiao Jin, Financial Controller (Age 55)
  • Yingping Chen, Sec.

What is Hebron Technology's stock symbol?

Hebron Technology trades on the NASDAQ under the ticker symbol "HEBT."

Who are Hebron Technology's major shareholders?

Hebron Technology's stock is owned by a number of retail and institutional investors. Top institutional shareholders include UBS Group AG (0.01%).

Which major investors are buying Hebron Technology stock?

HEBT stock was acquired by a variety of institutional investors in the last quarter, including UBS Group AG.

How do I buy shares of Hebron Technology?

Shares of HEBT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Hebron Technology's stock price today?

One share of HEBT stock can currently be purchased for approximately $18.40.

How big of a company is Hebron Technology?

Hebron Technology has a market capitalization of $299.37 million and generates $21.10 million in revenue each year. Hebron Technology employs 89 workers across the globe.

What is Hebron Technology's official website?

The official website for Hebron Technology is www.china-xbl.com.

How can I contact Hebron Technology?

Hebron Technology's mailing address is NO. 936 JINHAI 2ND ROAD KONGGANG NEW AREA LONGWAN DISTRICT, WENZHOU F4, 00000. The industrial products company can be reached via phone at 86-577-8689-5678 or via email at [email protected]

This page was last updated on 8/5/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.